# Liraglutide vs Exenatide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/liraglutide-vs-exenatide

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) Liraglutide vs Exenatide

Compared side by side

# Liraglutide vs exenatide: how they differ

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Both are GLP-1 receptor agonists given as frequent shots: exenatide, a copy of exendin-4 from Gila monster venom, lasts about 2.4 hours and is taken before the two main meals, and liraglutide, semaglutide’s predecessor, lasts about 13 hours and is taken once a day. Exenatide was FDA-approved in 2005, as Byetta, for blood sugar control in type 2 diabetes, and its US products are being discontinued; liraglutide is FDA-approved for type 2 diabetes as Victoza and for weight management as Saxenda. Commonly reported: a smaller appetite and nausea in the first weeks of exenatide, and on liraglutide appetite dropping and meals ending sooner, with nausea during the climb to 3 mg.

## Side by side

| Compared | [Liraglutide](https://pepvault.app/peptides/liraglutide) | [Exenatide](https://pepvault.app/peptides/exenatide) |
| --- | --- | --- |
| Category | Metabolic & GLP-1 | Metabolic & GLP-1 |
| Also known as | Victoza, Saxenda, Liraglutide injection | Byetta, Exendin-4, AC2993 |
| What it is | The predecessor to semaglutide: a GLP-1 receptor agonist that reduces appetite and improves blood sugar control, given as a daily injection rather than weekly. | The first GLP-1 drug, made from a peptide found in Gila monster venom, approved in 2005 as Byetta for type 2 diabetes: a shot before breakfast and dinner that lowers blood sugar after meals. |
| How it works | GLP-1 receptor agonist and predecessor to semaglutide. Stimulates insulin secretion, reduces glucagon, slows gastric emptying, and reduces appetite. Shorter half-life than semaglutide requiring daily dosing. FDA approved for type 2 diabetes (Victoza) and obesity (Saxenda). The labels step the dose up from 0.6 mg to minimize GI side effects. | The first GLP-1 receptor agonist approved: a synthetic copy of exendin-4, a 39-amino-acid peptide first found in the venom of the Gila monster, whose sequence partly overlaps human GLP-1. It releases insulin when glucose is high, lowers glucagon and slows stomach emptying, and it reduces food intake. It is cleared by the kidneys with a half-life of about 2.4 hours, so the original form (Byetta) is a shot before the two main meals of the day. FDA-approved in 2005 for type 2 diabetes in adults; it is not approved for weight management, and every US exenatide product is now listed as discontinued. |
| Commonly reported | Appetite drops and meals end sooner, though less dramatically than on semaglutide or tirzepatide, with nausea during the climb to 3 mg. FDA-approved for diabetes (Victoza) and obesity (Saxenda), with one of the longest track records of any GLP-1 drug. | A smaller appetite and nausea in the first weeks, easing for most people with time. Every US exenatide product, including the weekly Bydureon BCise, is now listed by the FDA as discontinued. |
| Studied range | FDA label: 0.6–3 mg, starting dose 0.6 mg. | FDA label: 5–10 mcg, starting dose 5 mcg. |
| How often | Daily SubQ | Twice daily SubQ, before meals |
| Half-life | ~13 hours | ~2.4 hours (FDA label) |
| Route | SubQ injection | SubQ injection |
| Typical run | FDA-approved for daily use. Community uses continuously or until goal reached. | FDA-approved for ongoing use in type 2 diabetes; the label's trials ran 16 to 30 weeks, with open-label extensions to 52 weeks. The once-weekly extended-release form (Bydureon, later Bydureon BCise) was studied for a median of 3.2 years in EXSCEL. |
| Evidence | Established: clinical trials or FDA-approved use exists | Established: clinical trials or FDA-approved use exists |
| Common side effects | Nausea, vomiting, diarrhea, constipation, pancreatitis risk, thyroid C-cell tumor risk (animal data) | Nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, indigestion, low blood sugar (with a sulfonylurea or insulin) |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking liraglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### Liraglutide

- Day 1–14 · 0.6 mg Starting dose — GI is the main thing
- Day 14–42 Titrating up — appetite really drops
- Day 42–168 Steady loss at target dose
- Day 168–365 Maintenance and long game

[Every card for liraglutide, with its sources](https://pepvault.app/peptides/liraglutide#weeks)

### Exenatide

- Day 1–30 · 5 mcg The 5 mcg start, before two meals
- Day 1–60 Why the shot comes before the meal
- Day 31–180 · 10 mcg 10 mcg, the full dose
- Day 181+ A medicine the market moved past

[Every card for exenatide, with its sources](https://pepvault.app/peptides/exenatide#weeks)

## With this comparison

### Liraglutide

- [Liraglutide: the full reference](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Mixing charts

- [Liraglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/liraglutide-10mg)

### Studies

- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022)
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021)
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016)
- [All 4 studies](https://pepvault.app/research#liraglutide)
- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)
- [Open-label](https://pepvault.app/glossary/open-label)

## Questions people ask

### How long do liraglutide and exenatide last?

The half-life of liraglutide is ~13 hours. The half-life of exenatide is ~2.4 hours (FDA label).

### How often are liraglutide and exenatide taken?

Liraglutide: daily SubQ. Route: SubQ injection. Exenatide: twice daily SubQ, before meals. Route: SubQ injection.

### How are liraglutide and exenatide dosed in research?

The FDA label range for liraglutide is 0.6–3 mg, with a 0.6 mg starting dose. The FDA label range for exenatide is 5–10 mcg, with a 5 mcg starting dose.

### What are the common side effects of liraglutide and exenatide?

For liraglutide, the library lists: nausea, vomiting, diarrhea, constipation, pancreatitis risk, thyroid C-cell tumor risk (animal data). For exenatide: nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, indigestion, low blood sugar (with a sulfonylurea or insulin).

## Each one in full

- [Liraglutide: dosage, half-life & reference guide](https://pepvault.app/peptides/liraglutide)
- [Exenatide: dosage, half-life & reference guide](https://pepvault.app/peptides/exenatide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking liraglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking liraglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### Liraglutide

- [Liraglutide: the full reference](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Mixing charts

- [Liraglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/liraglutide-10mg)

### Studies

- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022)
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021)
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016)
- [All 4 studies](https://pepvault.app/research#liraglutide)
- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Taking liraglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Metabolic & GLP-1 peptides](https://pepvault.app/peptides#metabolic)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
